Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2016-9723
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM QRadar 7.2 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM Reference #: 1999534.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM QRadar SIEM和QRadar Incident Forensics 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM QRadar SIEM和QRadar Incident Forensics都是美国IBM公司的产品。前者是一套利用安全智能保护资产和信息远离高级威胁的解决方案;后者是一套安全取证调查软件。 IBM QRadar SIEM和QRadar Incident Forensics 7.2.n版本中存在跨站脚本漏洞。远程攻击者可利用该漏洞在Web UI中注入任意的JavaScript脚本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBM CorporationQRadar SIEM 7.1 MR1 -
II. Public POCs for CVE-2016-9723
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2016-9723
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2016-9723

No comments yet


Leave a comment